mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.073 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.7 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.017 |
0.7 |